Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes
Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes
栏目名称
Correspondence
DOI
10.1097/CM9.0000000000001574
发布时间
2025-03-04
基金项目
National Science Foundation of Hunan Province for Excellent Young Scholars
National Key Research and Development Project
Natural Science Foundation of China (NSFC) grant
Natural Science Foundation of Hunan Province
- 浏览8
- 被引0
- 下载0

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文